The 20th anniversary of the German CLL Study Group and the importance of collaboration
Common side-effects of BTK inhibitors (ibrutinib and acalabrutinib) in the treatment of CLL
Novel therapies for the treatment of CLL, MCL and FL
Are complex karyotypes reliable prognostic markers for CLL?
What does the CLL forum data tell us?